JPH05320203A - Methylated galactosamine polymer and antibacterial containing the same - Google Patents

Methylated galactosamine polymer and antibacterial containing the same

Info

Publication number
JPH05320203A
JPH05320203A JP15121992A JP15121992A JPH05320203A JP H05320203 A JPH05320203 A JP H05320203A JP 15121992 A JP15121992 A JP 15121992A JP 15121992 A JP15121992 A JP 15121992A JP H05320203 A JPH05320203 A JP H05320203A
Authority
JP
Japan
Prior art keywords
polygalactosamine
galactosamine
methylated
molecular weight
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15121992A
Other languages
Japanese (ja)
Inventor
Yuichi Arai
井 祐 一 荒
Kaname Hasegawa
谷 川 要 長
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Higeta Shoyu Co Ltd
Original Assignee
Higeta Shoyu Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Higeta Shoyu Co Ltd filed Critical Higeta Shoyu Co Ltd
Priority to JP15121992A priority Critical patent/JPH05320203A/en
Publication of JPH05320203A publication Critical patent/JPH05320203A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE:To obtain a methylated galactosamine polymer which is improved in solubility and physiological activity especially antibacterial activity by methylating the amino or hydroxyl groups of a specified alpha-1,4-polygalactosamine. CONSTITUTION:A methylated galactosamine polymer of the formula (wherein R1 to R3 are each amino, methylamino, dimethylamino or trimethylamino; R4 to R11 are each H or methyl; and n is 0-20000) is obtained by dispersing alpha-1,4- polygalactosamine produced by a mold paecylomyces sp. I-1, a partially hydrolyzed polygalactosamine prepared by hydrolyzing it with an acid or an enzyme and filtering the product through an ultrafilter membrane to form a fraction of a definite molecular weight, a galactosamine oligosaccharide prepared by separating the hydrolyzate by ion exchange chromatography or a hydrochloride thereof in N-methyl-2-pyrrolidone, leaving the dispersion at rest at room temperature for 6-24hr, adding 1-2 N NaOH to it, and methylating the amino or hydroxyl groups of the galactosamine with methyl iodide and sodium iodide. The amino groups may be selectively methylated.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規ガラクトサミン重
合体メチル化物及びその用途に関するものである。
TECHNICAL FIELD The present invention relates to a novel methylated galactosamine polymer and its use.

【0002】[0002]

【従来の技術及び問題点】α−1,4ポリガラクトサミ
ン(ガラクトサミン重合体)は、本発明者らにより和歌
山県の土壌から新たに分離された糸状菌ペエシロマイセ
スsp.I−1(Paecilomyces sp.I
−1)(FERM BP−1180)が菌体外に多量に
生産する塩基性多糖であって、その本体はガラクトサミ
ンがα−1,4結合しているホモ多糖であり(特公昭5
6−12639,特公平1−41160)、その平均分
子量は300000である。そして、このα−1,4ポ
リガラクトサミンには抗菌活性(月刊フードケミカル4
月号,27(1989))や免疫賦活作用(J.Pha
rmacobio−Dyn,11,58−65(198
9))を有することが明らかにされている。しかし、各
種溶媒における溶解性等の問題があり物性の改善が望ま
れていた。
2. Description of the Related Art α-1,4 polygalactosamine (polymer of galactosamine) is a filamentous fungus Peethilomyces sp., Which was newly isolated from the soil of Wakayama prefecture by the present inventors. I-1 (Paecilomyces sp. I)
-1) (FERM BP-1180) is a basic polysaccharide produced in large amounts outside the cells, the main body of which is a homopolysaccharide in which galactosamine is α-1,4-linked (Japanese Patent Publication No.
6-12639, Japanese Patent Publication No. 1-41160), and its average molecular weight is 300,000. And this α-1,4 polygalactosamine has an antibacterial activity (monthly food chemical 4
Monthly issue, 27 (1989)) and immunostimulatory action (J. Pha
rmacobio-Dyn, 11 , 58-65 (198).
9)) has been revealed. However, there are problems such as solubility in various solvents, and improvement of physical properties has been desired.

【0003】また、類似の多糖であるキチン・キトサン
においても、その物性の改良及び生理的機能を向上させ
る目的で化学修飾による試みが数多くなされており、例
えば、キチンのカルボキシメチル化による水溶性の向上
及び金属イオンの吸着力の向上や、キトサンのトリメチ
ル化による水溶性の向上等、その成果も数多く報告され
ている(キチン、キトサンの応用、技報堂(199
0))。
Also, with respect to chitin and chitosan, which are similar polysaccharides, many attempts have been made by chemical modification for the purpose of improving their physical properties and physiological functions, and for example, water solubility by chitin carboxymethylation has been investigated. A number of such achievements have been reported (improvement of metal ion adsorption power, improvement of water solubility by trimethylation of chitosan, application of chitin and chitosan, Gihodo (199).
0)).

【0004】本発明は、ガラクトサミン重合体を化学的
に修飾して、メチル化誘導体を調製することにより、物
性が改善されかつ、生理活性の向上した新規ガラクトサ
ミン重合体の誘導体及び該誘導体を有効成分とする抗菌
剤に関するものであるが、このようなメチル化誘導体は
従来未知の新規化合物であるし、それを有効成分とする
抗菌剤も従来知られておらず新規である。
The present invention provides a derivative of a novel galactosamine polymer having improved physical properties and physiological activity by chemically modifying a galactosamine polymer to prepare a methylated derivative, and the derivative as an active ingredient. However, such a methylated derivative is a novel compound which has not been known so far, and an antibacterial agent containing it as an active ingredient has not been known so far and is novel.

【0005】[0005]

【問題点を解決するための手段】本発明者らは、上記し
た技術の現状に鑑み、ガラクトサミン重合体の物性の改
善及び生理活性の向上を目的として鋭意検討した結果、
アミノ基または水酸基にメチル基を導入することにより
溶解性が著しく向上し、生理活性、特に抗菌活性が向上
することを見出し本発明を完成した。
[Means for Solving the Problems] In view of the above-mentioned state of the art, the present inventors have earnestly studied for the purpose of improving physical properties and physiological activity of galactosamine polymers.
The present invention has been completed by finding that the introduction of a methyl group into an amino group or a hydroxyl group significantly improves the solubility and improves the physiological activity, particularly the antibacterial activity.

【0006】本発明に用いるガラクトサミン重合体は、
α−1,4ポリガラクトサミンを用いてもよいし、α−
1,4ポリガラクトサミンを酸または酵素で加水分解し
た後、限外濾過膜を用いて一定の分子量に分画したもの
(部分分解ポリガラクトサミン)、又は加水分解物をイ
オン交換クロマトグラフィーで分離後分取することによ
って得られるガラクトサミノオリゴ糖もしくはそれらの
塩酸塩を用いてもよい。
The galactosamine polymer used in the present invention is
α-1,4 polygalactosamine may be used, or α-
After hydrolyzing 1,4 polygalactosamine with an acid or enzyme, it was fractionated to a certain molecular weight using an ultrafiltration membrane (partially degraded polygalactosamine), or the hydrolyzate was separated by ion exchange chromatography. You may use the galactosamino oligosaccharide obtained by taking it, or those hydrochlorides.

【0007】部分分解ポリガラクトサミンの調製及び分
画法を説明すると、塩酸加水分解は、例えば、2−10
Nの塩酸とポリガラクトサミンとを、60−100℃で
6−24時間反応させればよい。一方ポリガラクトサミ
ン分解酵素による加水分解は、ポリガラクトサミン溶液
にポリガラクトサミン分解酵素を添加して35〜40℃
で反応させればよい。ポリガラクトサミン分解酵素とし
ては、例えばシュードモナスsp H881(特公平3
−8757,FERM P−8955)由来の酵素を用
いることができる。
The method for preparing and fractionating partially decomposed polygalactosamine will be described.
N hydrochloric acid and polygalactosamine may be reacted at 60-100 ° C for 6-24 hours. On the other hand, hydrolysis with polygalactosamine degrading enzyme is performed by adding polygalactosamine degrading enzyme to a polygalactosamine solution at 35 to 40 ° C.
You can react with. Examples of the polygalactosamine degrading enzyme include Pseudomonas sp H881 (Japanese Patent Publication No.
-8757, FERM P-8955) -derived enzyme can be used.

【0008】このように酸もしくは酵素によって加水分
解されたポリガラクトサミンは限外濾過膜等によって分
画し、各種の分画分子量単位に分けることができる。例
えば、加水分解された部分分解物を分画分子量1000
00、30000、10000、3000等の限外濾過
膜にて限外濾過を行い分画することでそれぞれ分画分子
量、100000以上、30000〜100000、1
0000〜30000、3000〜10000、300
0以下とに分画することができる。これらを凍結乾燥
し、各々の分子量の部分分解ポリガラクトサミンを得る
ことができる。
The polygalactosamine thus hydrolyzed by an acid or an enzyme can be fractionated by an ultrafiltration membrane or the like to be divided into various fractionated molecular weight units. For example, the partially hydrolyzed product is subjected to molecular weight cut-off of 1,000
The molecular weight cutoff is 100,000 or more, 30,000 to 100,000, 1 or more by ultrafiltration with an ultrafiltration membrane of 00, 30000, 10000, 3000, etc.
0000-30000, 3000-10000, 300
It can be fractionated to 0 or less. These can be lyophilized to obtain partially decomposed polygalactosamine of each molecular weight.

【0009】またガラクトサミノオリゴ糖は前記部分分
解ポリガラクトサミンを得るのと同様に酸又は分解酵素
による加水分解によって加水分解したのち、陽イオン交
換クロマトによりそれぞれのオリゴ糖を得ることができ
る(特開平2−19392)。また、市販のもの(フナ
コシ社製)を使用することもできる。
Galactosamino oligosaccharides can be hydrolyzed by hydrolysis with an acid or a degrading enzyme in the same manner as in the case of obtaining the partially degraded polygalactosamine, and then each oligosaccharide can be obtained by cation exchange chromatography (special Kaihei 2-19392). Moreover, a commercially available product (manufactured by Funakoshi Co., Ltd.) can also be used.

【0010】このようにして得られた各分画分子量の部
分分解ポリガラクトサミンもしくは、α−1,4ポリガ
ラクトサミン又はガラクトサミノオリゴ糖をメチル化す
るには、常法に従えばよく、例えばDomard法(I
nt.J.Biol.Macromo1.,,105
(1986))、またはMuzzarelli法(Ca
rbohydr.Polym.,,297(198
5))によって調製することができる。例えば、これら
をN−メチル−2−ピロリドンに分散させ、室温で6−
24時間放置したのち、1.0−2.0MのNaOHを
添加しヨウ化メチル(CH3I)及びヨウ化ナトリウム
(NaI)を加えメチル化させる。この後4倍量エタノ
ールを加え、折出した沈澱画分を遠心にて回収する。回
収した沈澱画分を水に溶解させたのち、イオン交換樹脂
カラムを通し、カラム通過画分を凍結乾燥してガラクト
サミン重合体メチル化物を高収率で得ることができる。
Methylation of the thus obtained partially decomposed polygalactosamine or α-1,4 polygalactosamine or galactosamino oligosaccharide of each molecular weight cut off may be carried out by a conventional method, for example, Domard. Law (I
nt. J. Biol. Macromo1. , 8 , 105
(1986)) or the Muzzarelli method (Ca
rbohydr. Polym. , 5 , 297 (198
5)). For example, these are dispersed in N-methyl-2-pyrrolidone and 6-
After standing for 24 hours, 1.0-2.0 M NaOH is added and methyl iodide (CH 3 I) and sodium iodide (NaI) are added to effect methylation. Then, 4-fold amount of ethanol is added, and the precipitated precipitate fraction is collected by centrifugation. The recovered precipitate fraction is dissolved in water, passed through an ion exchange resin column, and the column-passed fraction is lyophilized to obtain a methylated galactosamine polymer in a high yield.

【0011】また、アミノ基のみを選択的にメチル化す
るには、例えば、α−1,4ポリガラクトサミン、部分
分解ポリガラクトサミンまたは、ガラクトサミノオリゴ
糖を水に懸濁させ酢酸を加えて溶解させた後、20%−
40%のホルムアルデヒドを添加し室温で10−30時
間反応させる。次に水素化ホウ素ナトリウムを徐々に加
えた後、NaOHでpHを9.0に調整し水中に分散さ
せる。遠心分離し得られた沈澱画分をアセトンで洗浄
し、溶液画分にはアセトンを添加し析出した沈澱を遠心
分離にて回収する。これらを減圧乾燥し、得られた粉末
を60℃−80℃で10−20時間乾燥し、アセトニト
リル、CH3I溶液に分散させ20−40時間攪拌反応
させソクッスレー抽出器を用いてジエチルエーテル抽出
を行い、濃縮、乾固させ、ガラクトサミン重合体N−メ
チル化物を得ることができる。
To selectively methylate only amino groups, for example, α-1,4 polygalactosamine, partially decomposed polygalactosamine or galactosamino oligosaccharide is suspended in water and acetic acid is added to dissolve it. 20%-
Add 40% formaldehyde and react at room temperature for 10-30 hours. Next, sodium borohydride is gradually added, and then the pH is adjusted to 9.0 with NaOH and dispersed in water. The precipitate fraction obtained by centrifugation is washed with acetone, acetone is added to the solution fraction, and the precipitated precipitate is collected by centrifugation. These were dried under reduced pressure, and the obtained powder was dried at 60 ° C to 80 ° C for 10 to 20 hours, dispersed in acetonitrile and CH 3 I solution, stirred and reacted for 20 to 40 hours, and extracted with diethyl ether using a Soxhlet extractor. The galactosamine polymer N-methylated product can be obtained by performing, concentrating and drying.

【0012】上記したDomardの方法によるガラク
トサミン重合体メチル化物の調製はガラクトサミン残基
のアミノ基及び水酸基がランダムにメチル化されるが、
非常に収率良くガラクトサミン重合体メチル化物を得る
ことができるのに対して、Muzzarelliの方法
によるガラクトサミン重合体N−メチル化物の調製は前
者に比べて収率はやや劣るものの、選択的にアミノ基に
メチル基を導入することができるという特徴をもってお
り、この方法も有利に利用することができる。
In the preparation of the galactosamine polymer methylated product by the above-mentioned Domard's method, the amino group and the hydroxyl group of the galactosamine residue are randomly methylated.
While the galactosamine polymer methylated product can be obtained in a very good yield, the galactosamine polymer N-methylated product prepared by the Muzzarelli method has a slightly inferior yield as compared with the former, but selectively has amino groups. It has a feature that a methyl group can be introduced into, and this method can be advantageously used.

【0013】このようにして得られたガラクトサミン重
合体メチル化物及びガラクトサミン重合体N−メチル化
物は、下記化3及び化4の構造を有する新規物質であ
る。
The galactosamine polymer methylated product and the galactosamine polymer N-methylated product thus obtained are novel substances having the structures of the following chemical formulas 3 and 4.

【0014】[0014]

【化3】 [Chemical 3]

【0015】[0015]

【化4】 [Chemical 4]

【0016】このようにして得られた種々のガラクトサ
ミン重合体メチル化物は、いずれも抗菌性が向上してお
り、本発明の抗菌剤の有効成分として有用なものであ
る。また、使用に際して、各々を単独で用いてもよく、
それらを数種類混合して用いてもよい。本発明は新規物
質すなわち、α−1,4ポリガラクトサミンメチル化
物、部分分解ポリガラクトサミンメチル化物、ガラクト
サミノオリゴ糖のメチル化物及び、それらを有効成分と
する抗菌剤である。本発明において、有効成分はそのま
ま添加料として、または各種液剤、粉剤に製剤化して抗
菌剤として、又はその原料ないし中間体としても利用す
ることができる。
The various methylated galactosamine polymers thus obtained have improved antibacterial properties, and are useful as an active ingredient of the antibacterial agent of the present invention. Also, when used, each may be used alone,
You may mix and use several kinds of them. The present invention is a novel substance, that is, a methylated α-1,4 polygalactosamine, a methylated partially decomposed polygalactosamine, a methylated galactosaminooligosaccharide, and an antibacterial agent containing them as an active ingredient. In the present invention, the active ingredient can be used as an additive as it is, or can be used as an antibacterial agent by formulating into various liquids or powders, or as a raw material or an intermediate thereof.

【0017】次に本発明の製造例及び実施例を示す。Next, production examples and examples of the present invention will be shown.

【0018】[0018]

【製造例1.α−1,4ポリガラクトサミンの製造】グ
ルコース600g、ポリペプトン60g、CaCl2
2H2O 125gを水道水17lに溶解し、濃NaO
H溶液でpH7.0に調整した後30l容ジャーファー
メンターに移した。
[Production Example 1. Production of α-1,4 polygalactosamine] Glucose 600 g, polypeptone 60 g, CaCl 2 ·
125 g of 2H 2 O was dissolved in 17 liters of tap water, and concentrated NaO
The solution was adjusted to pH 7.0 with H solution and transferred to a 30 l jar fermenter.

【0019】この培地溶液に蒸気を注入することにより
加圧、加熱減菌(121℃、20分間)を行った。冷却
後の培地(最終液量20l)に、500ml三角フラス
コに150ml同組成の培地(グルコース3%、ポリペ
プトン0.3%、CaCl20.5%、pH7.0)で
26℃、4日間振とう培養したペエシロマイセスI−1
(FERM BP−1180)を容量比で約10%無菌
的に接種した。接種後27℃、通気量0.5VVM、攪
拌数200RPMの条件で5日間培養した。
By injecting steam into this medium solution, pressurization and heat sterilization (121 ° C., 20 minutes) were performed. The cooled medium (final liquid volume 20 l) was shaken in a 500 ml Erlenmeyer flask with 150 ml medium of the same composition (glucose 3%, polypeptone 0.3%, CaCl 2 0.5%, pH 7.0) at 26 ° C. for 4 days. Cultured Pesylomyces I-1
(FERM BP-1180) was aseptically inoculated at a volume ratio of about 10%. After inoculation, the cells were cultivated for 5 days under the conditions of 27 ° C., aeration rate of 0.5 VVM, and stirring number of 200 RPM.

【0020】培養終了後培養物を濾布濾過することによ
り培養濾液17lを得た。この培養濾液を50℃〜60
℃に加熱しながら分画分子量160000の限外濾過膜
(三菱レイヨン・エンジニアリング社製UF膜チューブ
ラーモジュールFタイプ)を通過させることにより、低
分子画分を除き液量が約3lになる迄濃縮した。更に、
約14000×Gで遠心分離することにより菌体残渣、
熱変性蛋白質を除去した。
After the completion of the culture, the culture was filtered through a filter cloth to obtain 17 l of culture filtrate. This culture filtrate is heated to 50 ° C to 60 ° C.
By passing through an ultrafiltration membrane (UF membrane tubular module F type manufactured by Mitsubishi Rayon Engineering Co., Ltd.) having a molecular weight cutoff of 160,000 while heating to ℃, the low molecular weight fraction is removed until the liquid volume is approximately 3 liters. did. Furthermore,
By centrifuging at about 14,000 × G, cell residue,
The heat-denatured protein was removed.

【0021】遠心分離後に上澄液画分3lに食塩約75
0g(約25%濃度)を加え攪拌し、溶解後、濃NaO
HでpHを7.0〜8.5に調整した。一夜放置し塩析
物を十分析出させた後、サラン製の布(塩化ビニリデン
と塩化ビニールの共重合体)上に塩析物を回収した。更
にこの塩析物の上から大量の微アルカリ性の水(pH
7.0以上)を撤布することにより余分の食塩及び培養
液に同時に混在している中性糖、その他の夾雑物を洗い
流した。
After centrifugation, about 75 ml of salt was added to 3 l of the supernatant fraction.
0 g (about 25% concentration) was added and stirred, and after dissolution, concentrated NaO
The pH was adjusted to 7.0-8.5 with H. After allowing to stand overnight to sufficiently deposit the salted-out product, the salted-out product was recovered on a cloth made of Saran (copolymer of vinylidene chloride and vinyl chloride). Furthermore, a large amount of slightly alkaline water (pH
(7.0 or more) was removed to wash away excess salt and neutral sugars and other contaminants simultaneously mixed in the culture solution.

【0022】次に、水洗後の塩析物に0.1M塩酸溶液
を容量比で約3倍量加え溶解した。この溶解物に濃Na
OH溶液を加えポリガラクトサミンの等電点であるpH
8.5に合わせた。一夜放置して十分析出物を析出させ
た後、上記と同様サラン製の布上に析出物を回収し、大
量の水道水で洗った。この水洗物をもう1度0.1M塩
酸に溶解後、等電点沈澱を行い水洗を繰り返すことによ
り精製した。この精製した析出物を121℃、15分間
減菌後、凍結乾燥することにより、α−1,4ポリガラ
クトサミンの精製粉末を7g得た。
Next, the salted out product after washing with water was dissolved by adding a 0.1 M hydrochloric acid solution in an amount of about 3 times by volume. Concentrated Na in this lysate
Addition of OH solution and pH, which is the isoelectric point of polygalactosamine
It was set to 8.5. After allowing to stand overnight to sufficiently deposit the precipitate, the precipitate was recovered on a Saran cloth as in the above, and washed with a large amount of tap water. This washed product was again dissolved in 0.1 M hydrochloric acid, and then subjected to isoelectric point precipitation and repeated washing with water for purification. The purified precipitate was sterilized at 121 ° C. for 15 minutes and then freeze-dried to obtain 7 g of purified powder of α-1,4 polygalactosamine.

【0023】[0023]

【製造例2.部分分解ポリガラクトサミンの調製】精製
α−1,4ポリガラクトサミン100gを4規定塩酸2
lに分散させ、冷却管付き三角フラスコ中にて、80
℃、6時間塩酸加水分解した。
[Production Example 2. Preparation of partially decomposed polygalactosamine] 100 g of purified α-1,4 polygalactosamine was added to 4N hydrochloric acid 2
in an Erlenmeyer flask equipped with a cooling tube.
Hydrochloric acid was hydrolyzed at 6 ° C for 6 hours.

【0024】分解後、この塩酸加水分解溶液を10規定
NaOHで中和しpH7とした。この溶液を先ず分画分
子量100000の限外濾過膜で処理(グレースジャパ
ン社製)し、濃縮画分(分画分子量100000以上)
と濾過画分(分画分子量100000以下)とに分画
し、次いでこの濾過画分を分画分子量30000の限外
濾過膜(グリースジャパン社製)にて同様に限外濾過を
行い、濃縮画分(分画分子量30000−10000
0)と濾過画分(分画分子量30000以下)とに分画
した。さらにこの濾過画分を分画分子量10000の限
外濾過膜(グレースジャパン社製)にて同様に限外濾過
を行い、濃縮画分(分画分子量10000−3000
0)と濾過画分(分画分子量10000以下)とに分
画、続いて濾過画分を分画分子量3000の限外濾過膜
(グレースジャパン社製)にて濾過し濃縮画分(分画分
子量3000−10000)と濾過画分(分画分子量3
000以下)とに分画した。これらをそれぞれマイクロ
アシライザーG3(旭化成社製)にて脱塩を行い、凍結
乾燥し、各々限外濾過膜による分画分子量100000
以上、30000−100000、10000−300
00、3000−10000、3000以下の各々のポ
リガラクトサミン部分分解物を得た。
After decomposition, this hydrochloric acid hydrolyzed solution was neutralized to pH 7 with 10N NaOH. This solution was first treated with an ultrafiltration membrane having a molecular weight cutoff of 100,000 (manufactured by Grace Japan) to obtain a concentrated fraction (molecular weight cutoff of 100,000 or more).
And a filtration fraction (molecular weight cutoff of 100,000 or less), and then this filtration fraction is similarly ultrafiltered with an ultrafiltration membrane (Grease Japan) having a molecular weight cutoff of 30,000 to obtain a concentrated fraction. Min (molecular weight cut-off 30,000-10000)
0) and the filtered fraction (molecular weight cutoff of 30,000 or less). Further, this filtration fraction was subjected to ultrafiltration in the same manner using an ultrafiltration membrane having a molecular weight cutoff of 10,000 (manufactured by Grace Japan) to obtain a concentrated fraction (molecular weight cutoff of 10,000-3000).
0) and a filtered fraction (molecular weight cutoff of 10,000 or less), and then the filtered fraction was filtered through an ultrafiltration membrane (made by Grace Japan) having a molecular weight cutoff of 3000 to obtain a concentrated fraction (molecular weight cutoff). 3000-10000) and filtered fraction (fraction molecular weight 3
000 or less). Each of these was desalted with Micro Acylyzer G3 (manufactured by Asahi Kasei Co., Ltd.), freeze-dried, and molecular weight cut-off by an ultrafiltration membrane was 100,000.
Above, 30,000-100,000, 10,000-300
A partially decomposed polygalactosamine of 00, 3000-10000, 3000 or less was obtained.

【0025】[0025]

【実施例1.ガラクトサミン重合体のメチル化】Example 1. Methylation of galactosamine polymer]

【0026】TM2−PG(α−1,4ポリガラクト
サミンメチル化物)の調製 α−1,4ポリガラクトサミン10gを500mlのN
−メチル−2−ピロリドンに分散させ、室温にて12時
間放置した。これに1.4M NaOH溶液86mlを
加え、次いでヨウ化メチル(CH3I)128g、ヨウ
化ナトリウム(NaI)18gを加え、36℃で3時間
振とうさせた。次いで4倍量エタノールを加え、析出し
た沈澱画分を遠心して集め、エタノール洗浄後、水に溶
解させ陰イオン交換樹脂カラム(DAIAION WA
10)に通した。カラム通過画分を凍結乾燥し、9gの
TM−PG(α−1,4ポリガラクトサミンメチル化
物)を得た。さらにメチル基の導入量を高めるために同
様の操作を繰り返し、8.1gのTM2−PGを得た。
その元素分析値C:H:N=38.2:6.78:4.
58より、ガラクトサミン残基1個あたり平均3.74
個のメチル基がアミノ基および水酸基に導入されたと推
定された。
Preparation of TM2-PG (methylated α-1,4 polygalactosamine) 10 g of α-1,4 polygalactosamine was added to 500 ml of N 2.
Dispersed in -methyl-2-pyrrolidone and left at room temperature for 12 hours. To this, 86 ml of 1.4 M NaOH solution was added, then 128 g of methyl iodide (CH 3 I) and 18 g of sodium iodide (NaI) were added, and the mixture was shaken at 36 ° C. for 3 hours. Then, 4-fold amount of ethanol was added, and the precipitated fractions were collected by centrifugation, washed with ethanol, and then dissolved in water to dissolve in an anion exchange resin column (DAIAION WA
I went to 10). The fraction passed through the column was freeze-dried to obtain 9 g of TM-PG (α-1,4 polygalactosamine methylated product). The same operation was repeated to further increase the amount of introduced methyl groups, to obtain 8.1 g of TM2-PG.
The elemental analysis value C: H: N = 38.2: 6.78: 4.
58, an average of 3.74 per galactosamine residue
It was presumed that individual methyl groups were introduced into the amino group and the hydroxyl group.

【0027】TM3−PG(α−1,4ポリガラクト
サミンメチル化物)の調製 実施例1−で得られたTM2−PG10gをさらにも
う1度実施例1−と同様の方法にてメチル化を行い、
9gのTM3−PGを得た。元素分析値C:H:N=4
1.3:6.95:4.3より、ガラクトサミン残基1
個あたり平均5.2個(2位のアミノ基に3個、3、6
位の水酸基にそれぞれ1個ずつ)のメチル基が導入され
たと推定された。
Preparation of TM3-PG (methylated α-1,4 polygalactosamine) 10 g of TM2-PG obtained in Example 1-was methylated again by the same method as in Example 1-
9 g of TM3-PG was obtained. Elemental analysis value C: H: N = 4
Galactosamine residue 1 from 1.3: 6.95: 4.3
An average of 5.2 (3 for the amino group at the 2-position, 3, 6
It was presumed that one methyl group was introduced into each hydroxyl group at each position).

【0028】TM2−3000(分画分子量3000
−10000ポリガラクトサミン部分分解物メチル化
物)の調製 製造例2で得た分画分子量3000−10000ポリガ
ラクトサミン部分分解物10gを実施例1−と同様の
方法でメチル化し7.2gのTM2−3000を得た。
元素分析値C:H:N=37.9:6.85:4.5よ
り、ガラクトサミン残基1個あたり平均3.9個のメチ
ル基がアミノ基および水酸基に導入されたことが推定さ
れた。
TM2-3000 (fraction molecular weight 3000
-10,000 Polygalactosamine partial degradation product methylated product) The fractionated molecular weight 3000-10000 polygalactosamine partial degradation product 10 g obtained in Production Example 2 was methylated by the same method as in Example 1-7.2 g of TM2-3000. Obtained.
From the elemental analysis values C: H: N = 37.9: 6.85: 4.5, it was estimated that an average of 3.9 methyl groups was introduced into the amino group and the hydroxyl group per galactosamine residue. ..

【0029】TM3−3000(分画分子量3000
−10000ポリガラクトサミン部分分解物メチル化
物)の調製 実施例1−で得られたTM2−3000(10g)を
さらにもう1度実施例1−と同様の方法にてメチル化
を行い、7.2gのTM3−3000を得た。元素分析
値C:H:N=41.4:7.59:4.33より、ガ
ラクトサミン残基1個あたり平均5.2個(2位のアミ
ノ基に3個、3、6位の水酸基にそれぞれ1個づつ)の
メチル基が導入されたことが推定された。
TM3-3000 (cut off molecular weight 3000
-10,000 Polygalactosamine partial decomposition product methylated product) TM2-3000 (10 g) obtained in Example 1-was methylated again by the same method as in Example 1-to give 7.2 g of TM3-3000 was obtained. From elemental analysis values C: H: N = 41.4: 7.59: 4.33, an average of 5.2 per galactosamine residue (3 in the amino group at the 2-position, hydroxyl groups at the 3 and 6-positions) It was presumed that one methyl group was introduced.

【0030】[0030]

【実施例2.ガラクトサミン重合体のN−メチル化】Example 2. N-methylation of galactosamine polymer]

【0031】N−M3−PG(α−1,4ポリガラク
トサミンN−トリメチル化物)の調製 α−1,4ポリガラクトサミン10gを400mlの水
に懸濁させ酢酸を10ml加えて溶解させた後、37%
のホルムアルデヒドを100ml添加し室温で20時間
反応させる。次に水素化ホウ素ナトリウム2.6gを徐
々に加えた後、NaOHでpHを9.0に調整し、水1
500mlに分散させる。これを遠心分離し沈澱画分を
アセトンで洗浄し、溶液画分にはアセトンを添加し、遠
心分離にて析出した沈澱を回収した。これらを減圧乾燥
し、乳鉢で粉砕後、80℃、17時間乾燥させた。乾燥
後アセトニトリル100ml、CH3I2.5ml溶液
に分散させ、36℃で30時間攪拌反応させ、ソクッス
レー抽出器を用いてジエチルエーテル抽出を行い、濃
縮、乾固させ、N−M3−PG4.85gを得た。その
元素分析値C:H:N=53.3:9.52:6.74
よりガラクトサミン残基1個あたり平均3.2個のメチ
ル基がアミノ基に導入されたN−トリメチル化物である
ことが推定された。
Preparation of N-M3-PG (α-1,4 Polygalactosamine N-Trimethylated Compound) 10 g of α-1,4 polygalactosamine was suspended in 400 ml of water and 10 ml of acetic acid was added to dissolve it. %
100 ml of formaldehyde of the above is added and reacted at room temperature for 20 hours. Next, 2.6 g of sodium borohydride was gradually added, and then the pH was adjusted to 9.0 with NaOH, and water 1
Disperse in 500 ml. This was centrifuged, the precipitate fraction was washed with acetone, acetone was added to the solution fraction, and the precipitate precipitated by centrifugation was recovered. These were dried under reduced pressure, pulverized in a mortar and then dried at 80 ° C. for 17 hours. After drying, it is dispersed in 100 ml of acetonitrile and 2.5 ml of CH 3 I , reacted with stirring at 36 ° C. for 30 hours, extracted with diethyl ether using a Soxhlet extractor, concentrated and dried to give 4.85 g of N-M3-PG. Obtained. The elemental analysis value C: H: N = 53.3: 9.52: 6.74
From the above, it was presumed that an average of 3.2 methyl groups per galactosamine residue was an N-trimethyl compound introduced into an amino group.

【0032】N−M3−3000(分画分子量300
0−10000ポリガラクトサミン部分分解物N−トリ
メチル化物)の調製 製造例2で得た分画分子量3000−10000ポリガ
ラクトサミン部分分解物10gを実施例2−と同様の
方法でN−トリメチル化し4.27gのN−M3−30
00を得た。その元素分析値C:H:N=52.9:
9.47:6.72より、ガラクトサミン残基1個あた
り平均3.2個のメチル基がアミノ基に導入されたN−
トリメチル化物であることが推定された。
N-M3-3000 (molecular weight cutoff 300
Preparation of 0-10000 polygalactosamine partially decomposed product N-trimethylated product) 10 g of the fractionated molecular weight 3000-10000 polygalactosamine partially decomposed product obtained in Production Example 2 was N-trimethylated in the same manner as in Example 2 to 4.27 g. N-M3-30
I got 00. The elemental analysis value C: H: N = 52.9:
From 9.47: 6.72, N- in which an average of 3.2 methyl groups per galactosamine residue was introduced into an amino group.
It was presumed to be a trimethylated product.

【0033】[0033]

【実施例3.各種ガラクトサミン重合体メチル化物の抗
菌作用】実施例2で得たTM2−PG、TM3−PG、
TM2−3000、TM3−3000、N−M3−PG
及びN−M3−3000の抗菌作用は、供試菌株をMu
eller Hinton Broth(pH7.0)
(Difco社製)にて30℃で1日培養した後、各ガ
ラクトサミン重合体メチル化物を各々最終濃度で10
0、50、25、12.5、6.25、3μg/mlに
なるように加えたMueller Hinton Br
oth(pH7.0)に植菌し、30℃、1日培養後の
菌の生育をOD660nmで測定して最少発育阻止濃度
(MIC)として決定した。結果は下記の表1に示し
た。
Example 3. Antibacterial Action of Various Methylated Galactosamine Polymers TM2-PG, TM3-PG obtained in Example 2
TM2-3000, TM3-3000, N-M3-PG
The antibacterial effect of N-M3-3000 is
eller Hinton Broth (pH 7.0)
After culturing for 1 day at 30 ° C. (manufactured by Difco), each galactosamine polymer methylated product was brought to a final concentration of 10
Mueller Hinton Br added to 0, 50, 25, 12.5, 6.25, 3 μg / ml
Oth (pH 7.0) was inoculated, and the growth of the bacteria after culturing at 30 ° C. for 1 day was measured at OD660 nm to determine the minimum inhibitory concentration (MIC). The results are shown in Table 1 below.

【0034】[0034]

【表1】[Table 1]

【0035】[0035]

【発明の効果】本発明によって、ガラクトサミン重合体
(N−)メチル誘導体が提供される。本誘導体は、従来
未知の新規化合物であって、物性が改善され、しかも抗
菌力も大幅に増大されたので、すぐれた抗菌剤として利
用することができる。
The present invention provides a galactosamine polymer (N-) methyl derivative. This derivative is a novel compound which has not been heretofore known, has improved physical properties, and has significantly increased antibacterial activity. Therefore, it can be used as an excellent antibacterial agent.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 下記化1に示される化学式を有するガラ
クトサミン重合体メチル化物。 【化1】
1. A methylated galactosamine polymer having a chemical formula shown in the following chemical formula 1. [Chemical 1]
【請求項2】 下記化2に示される化学式を有するガラ
クトサミン重合体N−メチル化物。 【化2】
2. A galactosamine polymer N-methylated product having the chemical formula shown below. [Chemical 2]
【請求項3】 請求項1及び/又は請求項2に記載のガ
ラクトサミン重合体メチル化物を有効成分とする抗菌
剤。
3. An antibacterial agent comprising the methylated galactosamine polymer according to claim 1 and / or 2 as an active ingredient.
JP15121992A 1992-05-20 1992-05-20 Methylated galactosamine polymer and antibacterial containing the same Pending JPH05320203A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15121992A JPH05320203A (en) 1992-05-20 1992-05-20 Methylated galactosamine polymer and antibacterial containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15121992A JPH05320203A (en) 1992-05-20 1992-05-20 Methylated galactosamine polymer and antibacterial containing the same

Publications (1)

Publication Number Publication Date
JPH05320203A true JPH05320203A (en) 1993-12-03

Family

ID=15513854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15121992A Pending JPH05320203A (en) 1992-05-20 1992-05-20 Methylated galactosamine polymer and antibacterial containing the same

Country Status (1)

Country Link
JP (1) JPH05320203A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009236600A (en) * 2008-03-26 2009-10-15 National Institute Of Advanced Industrial & Technology Mass analyzing method of sugar compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009236600A (en) * 2008-03-26 2009-10-15 National Institute Of Advanced Industrial & Technology Mass analyzing method of sugar compound

Similar Documents

Publication Publication Date Title
JPH07504928A (en) High-molecular glucuronic acid compounds, their production methods and uses, especially as gelling agents, viscosity-imparting agents, moisture-imparting agents, stabilizers, chelating agents, or flocculants
JPH09324001A (en) Purification method for sodium hyaluronate
JPH08259602A (en) New polysaccharide substance
WO2001002597A1 (en) Process for the preparation of the polysaccharides k4 and k5 from escherichia coli
EP0867453A2 (en) A method of purifying sodium hyaluronate
Omer et al. Preparation of Isatin/chitosan schiff base as novel antibacterial biomaterials
JP3181337B2 (en) Method for producing chitosan oligosaccharide mixture and method for producing chitin oligosaccharide mixture
JPH05320203A (en) Methylated galactosamine polymer and antibacterial containing the same
WO2018146698A1 (en) Improved method for the preparation of sulfobutylether beta cyclodextrin sodium
EP0067000B1 (en) Production of a nitrogen-containing polysaccharide having antitumour activity
JP3722522B2 (en) Process for producing β-1,3-glucan
JP2763112B2 (en) Water-soluble low molecular weight chitosan and method for producing the same
US5760213A (en) Immunoactivating agent
JPS58129001A (en) Novel immunoligically active polyglucide and its preparation
JP2758475B2 (en) Chitosan oligomer and method for producing the same
JPH0222301A (en) Production of water-soluble chitosan
KR100407790B1 (en) Manufacturing method chitosan derivatives
KR100551585B1 (en) Method for preparing water-soluble oligosaccharide of glucuronic acid using gluconacetobacter hansenii pjk
KR100252704B1 (en) Method of making n,o-carboxy methyl chitosan with high purity crystallization and a method of controlling a molecular weight of water-soluble chitosan
JP2750993B2 (en) BS-5 substance and method for producing the same
GB2262531A (en) Antiviral sulphated polysaccharides
JP3826168B2 (en) Polysaccharides derived from microorganisms
JPH0587238B2 (en)
CN113293185A (en) Preparation method of chitosan oligosaccharide
KR840001359B1 (en) Process for the production of polysaccharide rbs substance